Cargando…
Midkine as a prognostic biomarker in oral squamous cell carcinoma
The aim of this study was to evaluate serum midkine (S-MK) concentrations as a prognostic tumour marker in oral squamous cell carcinoma (OSCC). We measured S-MK concentrations in patients with OSCC and healthy volunteers. In addition, we performed real-time quantitative reverse transcription–PCR ana...
Autores principales: | Ota, K, Fujimori, H, Ueda, M, Shiniriki, S, Kudo, M, Jono, H, Fukuyoshi, Y, Yamamoto, Y, Sugiuchi, H, Iwase, H, Shinohara, M, Ando, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527829/ https://www.ncbi.nlm.nih.gov/pubmed/18682710 http://dx.doi.org/10.1038/sj.bjc.6604539 |
Ejemplares similares
-
Clinical significance of midkine expression in pancreatic head carcinoma
por: Maeda, S, et al.
Publicado: (2007) -
Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma
por: Yoshida, R, et al.
Publicado: (2014) -
EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers
por: Fukuyoshi, Y, et al.
Publicado: (2008) -
Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006) -
Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma
por: Liu, J-L, et al.
Publicado: (2014)